Why the study?
Do CAPD patients have worse lipid profiles compared to IgA nephropathy and HD patients?
Do CAPD patients have worse lipid profiles compared to IgA nephropathy and HD patients?
CAPD patients exhibit a more pro-atherogenic lipid profile, including elevated Lp(a), compared to hemodialysis and IgA nephropathy patients.
CAPD patients may warrant closer lipid monitoring; hypothesis-generating and leaves causal CV risk open for prospective study.
No takes yet. Share an insight, caveat, or question.
Ohashi et al. (1992) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: